Disease Info Card

Xeroderma Pigmentosum Complementation Group A

Information about Xeroderma Pigmentosum Complementation Group A: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Xeroderma Pigmentosum Complementation Group A

Most recent studies have shown that Xeroderma Pigmentosum Complementation Group A shares some biological mechanisms with anemia, ataxia, ataxia-telangiectasia, carcinogenesis, carcinoma, cell-transformation-neoplastic, cockayne-syndrome, fanconi-anemia, hereditary-diseases, lung-neoplasms, malignant-neoplasm-of-skin, malignant-neoplasms, malignant-squamous-cell-neoplasm, neoplasms, skin-neoplasms, xeroderma, xeroderma-pigmentosum, xeroderma-pigmentosum-group-d, xeroderma-pigmentosum-group-f, xeroderma-pigmentosum-group-g.

Among the many pathways, these few ones have gauged particular interests from scientists studying Xeroderma Pigmentosum Complementation Group A, and have been seen in publications frequently: Aging, Cell Cycle, Cell Cycle Arrest, Cell Cycle Checkpoint, Cell Death, Cell Killing, Cell Proliferation, Dna Excision, Dna Repair, Dna Replication, G2 Phase, Hypersensitivity, Localization, Mismatch Repair, Nucleotide-excision Repair, Response To Uv, S Phase, Sensitization, Spermatogenesis, Translesion Synthesis

Quite a number of genes have been found to play important roles in Xeroderma Pigmentosum Complementation Group A, such as CAT, CDKN1A, CRAT, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, GLYAT, GTF2H1, GTF2H5, NR1H2, PCNA, POLH, POLR1A, RPA1, TP53, XPA, XPC. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.